相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients
Y. Zhao et al.
ANNALS OF ONCOLOGY (2013)
Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial
Young-Hwa Chung et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study
Wei Bai et al.
JOURNAL OF DIGESTIVE DISEASES (2013)
Treatment of Hepatocellular Carcinoma Combining Sorafenib and Transarterial Locoregional Therapy: State of the Science
Joshua L. Weintraub et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
Joong-Won Park et al.
LIVER INTERNATIONAL (2013)
Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses
Gwang Hyeon Choi et al.
RADIOLOGY (2013)
Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma
Adnan Muhammad et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
Xu-Dong Qu et al.
BMC CANCER (2012)
Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
Wolfgang Sieghart et al.
EUROPEAN RADIOLOGY (2012)
Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
Joong-Won Park et al.
JOURNAL OF HEPATOLOGY (2012)
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial
Domenico Sansonno et al.
ONCOLOGIST (2012)
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
R. Cabrera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Evolving strategies for the treatment of hepatocellular carcinoma: From clinical-guided to molecularly-taylored therapeutic options
Luca Faloppi et al.
CANCER TREATMENT REVIEWS (2011)
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
J. -L. Raoul et al.
CANCER TREATMENT REVIEWS (2011)
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
Masatoshi Kudo et al.
EUROPEAN JOURNAL OF CANCER (2011)
Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
Timothy M. Pawlik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study
Jean-Francois Dufour et al.
ONCOLOGIST (2010)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib® versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794]
K. Hoffmann et al.
BMC CANCER (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
分享论文
